Garg Group: Federal and Delaware Courts Clear Path for Consent Solicitation
BETR sits 29% above its 52-week low of $11.111.
Summary
Federal and Delaware courts have cleared the way for Vishal Garg's consent solicitation to remove five Better Home & Finance directors, confirming that stockholders can vote without triggering the poison pill or facing litigation.
Key Events · Legal and Risk Events · BETR
-
Federal Court Denies Injunction
The U.S. District Court for the Southern District of New York denied Better's application for a temporary restraining order and preliminary injunction, allowing the Garg Group's consent solicitation to proceed.
-
Delaware Court Confirms Poison Pill Carveout
At an August 28, 2026 hearing, the Delaware Court of Chancery confirmed that signing and delivering a GREEN consent card will not trigger the poison pill, based on the public solicitation carveout in the rights plan.
-
Better's Own Counsel Agrees
Better's counsel confirmed at the Delaware hearing that the poison pill permits Garg to solicit consents through a qualifying public solicitation without aggregating consenting shares.
-
Path Cleared for Director Removal Vote
Stockholders can now vote on removing five directors — Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan, and Harit Talwar — without fear of litigation or triggering the poison pill.
Analysis · BETR · Finance
The Garg Group's consent solicitation to remove five Better Home & Finance directors has cleared two significant legal hurdles. The federal court in the Southern District of New York denied Better's request for a temporary restraining order and preliminary injunction, ruling that stockholders are adequately informed to make their own voting decisions and that private securities litigation should not be used to chill stockholder democracy. Separately, at an August 28, 2026 hearing, the Delaware Court of Chancery confirmed — with Better's own counsel agreeing — that signing and returning a GREEN consent card will not trigger the company's recently adopted poison pill, because the rights plan contains a public solicitation carveout. This removes a key deterrent that Better had been using to discourage stockholder participation in the consent process. The practical effect is that the path is now clear for stockholders to vote on removing five directors, including interim CEO Daniel Lewis, without fear of litigation or triggering the poison pill. This materially shifts the balance of power in the ongoing boardroom fight toward Garg and his group.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BETR was trading at $14.30 on NASDAQ in the Finance sector, with a market capitalization of approximately $275M. The 52-week trading range was $11.11 to $94.06. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.